Click
Chat
 
Du kan vedhæfte PDF, JPG, PNG, DOC(X), XLS(X) og TXT-filer. Klik på ikonet, vælg fil og vent til upload er færdig før du indsender eller uploader endnu en fil.
60
Vedhæft Send
Historik

Vælg chat via ovenstående menu
Luk reklame

DANMARKS STØRSTE INVESTORSITE MED DEBAT, CHAT OG NYHEDER

Genmab: Video - Subcutaneous epcoritamab


84757 Helge Larsen/PI-redaktør 19/6 2020 17:19
Oversigt

Martin Hutchings, MD, PhD, of Copenhagen University Hospital, Copenhagen, Denmark, discusses the results from a Phase I/II dose-escalation study investigating subcutaneous epcoritamab (CD3xCD20) in patients with relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma. Additionally, Dr Hutchings outlines safety signals detected during the clinical trial. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).




TRÅDOVERSIGT